Exploring the Resurgence of a Neglected Disease: Lessons From the 2023–2024 Mpox Outbreak in Rio de Janeiro, Brazil
Author:
Silva Mayara Secco Torres1ORCID, Coutinho Carolina1, Torres Thiago Silva1, Magalhães Monica Avelar2, Yanavich Carolyn1, Echeverría-Guevara Amanda1, Bastos Matheus Oliveira1, Martins Pedro Silva1, Mesquita Maira Braga1, Reges Paula Pereira de Souza1, Meneguetti Maria Roberta1, Santana Ana Paula Lovetro1, Terra Marcela1, Nunes Estevão Portela1, Lessa Flavia Cristina Serrão1, Moreira Ronaldo Ismério1, Peixoto Eduardo Mesquita1, Paulo Karolyne Wolch de Almeida3, Sant’Ana Andryelle Cristina3, Elias da Silva Edson3, Cardoso Sandra Wagner1, Veloso Valdilea Gonçalves1, Grinsztejn Beatriz1, Soares João Paulo Bortot, Hottz Giselle, Santos Cicero, Rendelli Bruna Fabris, Tuccori Luciana Patricia, Neto Jadir Rodrigues Fagundes, Freitas Lucilene, Wakimoto Mayumi, Azevedo Katia, Escada Rodrigo Otavio da Silva, Ribeiro Maria Pia Diniz, Tavares Isabel Cristina Ferreira, Santos Desirée Vieira, Camacho Luiz Ricardo Siqueira, Rosadas Leonardo, Fares Luisa, Amparo Pedro, Andrade Hugo Boechat, Coutinho José Ricardo Hildebrant, Barbosa Hugo Perazzo Pedroso, Nazer Sandro, Calvet Guilherme Amaral, Menezes Rodrigo Caldas, Pereira Sandro Antônio,
Affiliation:
1. Instituto Nacional de Infectologia Evandro Chagas, Fiocruz , Rio de Janeiro , Brazil 2. Instituto de Comunicação e Informação Científica e Tecnológica em Saúde, Fiocruz , Rio de Janeiro , Brazil 3. Instituto Oswaldo Cruz, Fiocruz , Rio de Janeiro , Brazil
Abstract
Abstract
Following the 2022 global mpox outbreak, diagnoses decreased worldwide, even in settings with limited vaccine access. In 2023–2024, a new outbreak emerged in Rio de Janeiro, Brazil, highlighting the importance of continuous surveillance, preventive measures such as vaccination in vulnerable populations, and treatment options, emphasizing equitable global health technology distribution.
Funder
Instituto Nacional de Infectologia Evandro Chagas Fundação Oswaldo Cruz Brazilian Ministry of Health Conselho Nacional de Desenvolvimento Científico e Tecnológico Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro
Publisher
Oxford University Press (OUP)
Reference12 articles.
1. Ambulatory and hospitalized patients with suspected and confirmed mpox: an observational cohort study from Brazil;Silva;Lancet Reg Health Am,2022
|
|